跳转至内容
Merck

[Drug treatments, from chlorpromazine to new molecules].

Soins. Psychiatrie (2013-06-14)
Adeline Gaillard, Marie-France Poirier
摘要

The history of drug treatments, and particularly the discovery of certain molecules, led toan evolution in psychiatric practices. The discovery of the therapeutic properties of chlorpromazine in 1952 by Jean Delay and Pierre Deniker revolutionised the relational process between patients and caregivers.The perspectives are encouraging, notably in the areas of schizophrenia and mood disorders.

材料
货号
品牌
产品描述

Sigma-Aldrich
氯丙嗪 盐酸盐, ≥98% (TLC)
Supelco
氯丙嗪盐酸盐标准液 盐酸盐, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®
Sigma-Aldrich
氯丙嗪 盐酸盐, meets USP testing specifications
Supelco
氯丙嗪 盐酸盐, VETRANAL®, analytical standard
氯丙嗪 盐酸盐, European Pharmacopoeia (EP) Reference Standard